Table 1c.
Autologous Patient Demographics and Baseline Characteristics
| Home HCT (N=17) | Matched Controls (N=34) | P-value1 | |
|---|---|---|---|
| Median Age (range) | 60 (46–74) | 61.5 (20–76) | 0.68 |
| Gender (female) | 4 (23.5%) | 15 (44.1%) | 0.15 |
| Race | 0.80 | ||
| White | 15 (88.2%) | 26 (76.5%) | · |
| Black | 2 (11.8%) | 7 (20.6%) | · |
| Other | 0 (0%) | 1 (2.9%) | · |
| Ethnicity (non-Hispanic) | 17 (100%) | 33 (97.1%) | 0.20 |
| Karnofsky Performance Status | 0.99 | ||
| 80 or below | 10 (58.8%) | 21 (61.8%) | · |
| 90–100 | 7 (41.2%) | 13 (38.2%) | · |
| Disease | 0.77 | ||
| Plasma Cell Dyscrasia | 11 (64.7%) | 20 (58.8%) | · |
| Lymphoma (HL+NHL)2 | 6 (35.3%) | 14 (41.2%) | · |
| Disease Status | 0.62 | ||
| First Complete Remission | 3 (17.6%) | 11 (32.4%) | · |
| 2nd or greater CR3 | 4 (23.5%) | 6 (17.6%) | · |
| Partial Remission | 10 (58.8%) | 17 (50%) | · |
| Stem cell source | 0.99 | ||
| Peripheral blood | 17 (100%) | 33 (97.1%) | · |
| Bone marrow/Peripheral blood | 0 (0%) | 1 (2.9%) | · |
1
P-values obtained via t-test or Chi-square test.
2
Lymphoma: Hodgkin Lymphoma + Non-Hodgkin Lymphoma.
3
CR: Complete Remission.